Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naldebain for Pain Management After Cesarean Section
NCT06344169Phase 3Recruiting
- Sponsor
- Buddhist Dalin Tzu Chi General Hospital
- Start
- May 2024
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dinalbuphine sebacate in postoperative pain, sponsored by Buddhist Dalin Tzu Chi General Hospital. Started May 2024; status: recruiting.
02
Drugs
dinalbuphine sebacate
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06344169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06344169.